Brain Awareness Video Contest

How Ketamine Treats Depression

  • Published4 Sep 2019
  • Source BrainFacts/SfN

In March 2019, the U.S. Food and Drug Administration approved ketamine for the treatment of depression — the first new antidepressant medication in decades. Unlike previous generations of antidepressants, ketamine targets the neurotransmitter glutamate. And, a single dose can work in just a few hours and the effects persist for weeks.

This video won second place in the 2019 Brain Awareness Video Contest.

CONTENTPROVIDEDBY

BrainFacts/SfN

Brain Awareness Video Contest

Submit a short video about any neuroscience topic for a chance to win $4,000 and a trip to SfN's Annual Meeting!

Learn More

Brain Awareness Week

A worldwide celebration of the brain that brings together scientists, families, schools, and communities during the third week in March.

Join the Campaign

BrainFacts Book

Download a copy of the newest edition of the book, Brain Facts: A Primer on the Brain and Nervous System.

Download